Non-muscle-invasive bladder cancer: The role of radical cystectomy

Urology

Volumn 66, Issue 5, 2005, Pages 917-922

  Chang, Sam S ^a   Cookson, Michael S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P21; PROTEIN P53; TUMOR MARKER;

ADJUVANT THERAPY; ANEUPLOIDY; BCG VACCINATION; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CELL CYCLE; CHEMOTHERAPY; CHROMOSOME 17P; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTECTOMY; DISEASE COURSE; DYSURIA; GENETIC DIFFERENCE; HIGH RISK PATIENT; HUMAN; ILEAL CONDUIT; IMMUNOTHERAPY; LYMPH VESSEL; METASTASIS; MINIMAL RESIDUAL DISEASE; MORBIDITY; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; ONCOGENE; PATIENT ATTITUDE; PATIENT COUNSELING; PERIOPERATIVE PERIOD; PHYSICIAN; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SALVAGE THERAPY; SOCIOECONOMICS; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TUMOR; TUMOR GROWTH; URINARY DIVERSION; UROGENITAL TRACT TUMOR; UROTHELIUM;

CYSTECTOMY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 27744606257     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.05.003     Document Type: Review

References (50)

1. J.A. Smith Jr, R.F. Labasky, A.T. Cockett American Urological Association Bladder Cancer Clinical Guidelines Panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS) J Urol 162 1999 1697 1701
2. H.W. Herr, P.C. Sogani Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296 1299
3. J.B. Thrasher, E.D. Crawford Current management of invasive and metastatic transitional cell carcinoma of the bladder J Urol 149 1993 957 972
4. F.M. Torti, B.L. Lum, D. Aston Superficial bladder cancer the primacy of grade in the development of invasive disease J Clin Oncol 5 1987 125 130
5. R. Cote, S.J. Chatterjee Molecular determinants of outcome in bladder cancer Cancer J Sci Am 5 1999 1 15
6. J. Leissner, C. Koeppen, H.K. Wolf Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy J Urol 169 2003 955 960
7. J.P. Stein Indications for early cystectomy Urology 62 2003 591 595
8. G.M. Farrow, D.C. Utz, C.C. Rife Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy Cancer Res 36 1976 2495 2501
9. A.F. Althausen, G.R. Prout Jr, J.J. Daly Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ J Urol 116 1976 575 580
10. S. Masood, S. Sriprasad, J.H. Palmer T1G3 bladder cancer - indications for early cystectomy Int Urol Nephrol 36 2004 41 44
11. M.S. Cookson, H.W. Herr, Z.F. Zhang The treated natural history of high risk superficial bladder cancer 15-year outcome J Urol 158 1997 62 67
12. J.I. Epstein, M.B. Amin, V. Reuter The World Health Organization/ International Society of Urological Pathology classification of urothelial (transitional cell) neoplasms of the urinary bladder Am J Surg Pathol 22 1998 1435 1448
13. L. Cheng, A.L. Weaver, R.M. Neumann Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer a new proposal Cancer 86 1999 1035 1043
14. Y. Hasui, Y. Osada, S. Kitada Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer Urology 43 1994 782 786
15. C.E. Platz, M.B. Cohen, M.P. Jones Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 9 1996 1035 1039
16. F. Millan-Rodriquez, G. Chechile-Tomiolo, J. Salvador-Bayarri Multivariate analysis of the prognostic factors of primary superficial bladder cancer J Urol 163 2000 73 80
17. W.H. Falor, R.M. Ward-Skinner The importance of marker chromosomes in superficial transitional cell carcinoma of the bladder 50 patients followed up to 17 years J Urol 139 1988 929 932
18. A.A. Sandberg Chromosome changes in bladder cancer clinical and other correlations Cancer Genet Cytogenet 19 1986 163 175
19. F.M. Waldman, P.R. Carroll, R. Kerschmann Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer Cancer Res 51 1991 3807 3813
20. A.D. Watters, J.J. Going, K.M. Grigor Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours Eur J Cancer 38 2002 1593 1599
21. J. Richter, U. Wagner, P. Schraml Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer Cancer Res 59 1999 5687 5691
22. G. Sauter, H. Moch, D. Moore Heterogeneity of erbB-2 gene amplification in bladder cancer Cancer Res 53 1993 2199 2203
23. S.J. Chatterjee, R. Datar, D. Youssefzadeh Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma J Clin Oncol 22 2004 1007 1013
24. S.C. Dutta, J.A. Smith Jr, S.B. Shappell Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy J Urol 166 2001 490 493
25. D.P. Wood Jr, J.E. Montie, J.E. Pontes Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer J Urol 141 1989 346 349
26. C.L. Amling, J.B. Thrasher, H.A. Frazier Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder J Urol 151 1994 31 36
27. J.P. Stein, D.G. Skinner Results with radical cystectomy for treating bladder cancer a "reference standard" for high-grade, invasive bladder cancer BJU Int 92 2003 12 17
28. F. Pagano, P. Bassi, T.P. Galetti Results of contemporary radical cystectomy for invasive bladder cancer a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 1991 45 50
29. M.S. Soloway, A.E. Lopez, J. Patel Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy Cancer 73 1994 1926 1931
30. M.A. Ghoneim, M.M. el-Mekresh, M.A. el-Baz Radical cystectomy for carcinoma of the bladder critical evaluation of the results in 1,026 cases J Urol 158 1997 393 399
31. J.A. Freeman, D. Esrig, J.P. Stein Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction Cancer 76 1995 833 839
32. F.J. Bianco Jr, D. Justa, D.J. Grignon Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy Urol Oncol 22 2004 290 294
33. M.L. Paik, M.J. Scolieri, S.L. Brown Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy J Urol 163 2000 1693 1696
34. H.W. Herr Routine CT scan in cystectomy patients does it change management? Urology 47 1996 324 325
35. M. Miladi, M. Peyromaure, M. Zerbib The value of a second transurethral resection in evaluating patients with bladder tumours Eur Urol 43 2003 241 245
36. H.W. Herr The value of a second transurethral resection in evaluating patients with bladder tumors J Urol 162 1999 74 76
37. M.O. Grimm, C. Steinhoff, X. Simon Effect of routine repeat transurethral resection for superficial bladder cancer a long-term observational study J Urol 170 2003 433 437
38. J. Rigaud, G. Karam, G. Braud T1 bladder tumors value of a second endoscopic resection Prog Urol 12 2002 27 30
39. H.W. Herr Neoadjuvant chemotherapy for invasive bladder cancer Semin Surg Oncol 5 1989 266 271
40. F.N. Joudi, M.A. O'Donnell Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures Curr Opin Urol 14 2004 271 275
41. D.L. Lamm, B.A. Blumenstein, J.D. Crissman Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder a randomized Southwest Oncology Group study J Urol 163 2000 1124 1129
42. J.M. Hassan, M.S. Cookson, J.A. Smith Jr Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy J Urol 172 2004 882 884
43. D. Esrig, J.A. Freeman, J.P. Stein Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder Semin Urol Oncol 15 1997 154 160
44. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
45. M.S. Cookson, S.S. Chang, N. Wells Complications of radical cystectomy for nonmuscle invasive disease comparison with muscle invasive disease J Urol 169 2003 101 104
46. M. Stockle, P. Alken, U. Engelmann Radical cystectomy - often too late? Eur Urol 13 1987 361 367
47. C. Wiesner, J. Pfitzenmaier, A. Faldum Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy BJU Int 95 2005 301 305
48. R.E. Hautmann, T. Paiss Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 159 1998 1845 1850
49. G.N. Thalmann, R. Markwalder, O. Shahin Primary T1G3 bladder cancer organ preserving approach or immediate cystectomy? J Urol 172 2004 70 75
50. J.J. Patard, A. Rodriguez, E. Leray Intravesical bacillus Calmette-Guérin treatment improves patient survival in T1G3 bladder tumours Eur Urol 41 2002 635 642